![Rik Derynck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rik Derynck is the founder of Pliant Therapeutics, Inc. Currently, Mr. Derynck is the Director at Eli & Edythe Broad Center of Regeneration Medicine & Stem Cell.
Formerly, Mr. Derynck was a Professor at The University of California, San Francisco.
Mr. Derynck completed graduate studies at Ghent University.
| Unternehmen | Position | Beginn |
|---|---|---|
Eli & Edythe Broad Center of Regeneration Medicine & Stem Cell | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | Gründer | - |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pliant Therapeutics, Inc.
 Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
Eli & Edythe Broad Center of Regeneration Medicine & Stem Cell |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
